The Claim

Thymogen nasal spray exhibits virucidal activity against respiratory syncytial virus in vitro, with effects initiating at a concentration of 1.2% in Vero cell cultures, suggesting potential antiviral properties against this respiratory pathogen.

Source: Virucidal Activity of the Drug «Thymogen®», a Nasal Dosed Spray, Against Human Respiratory Viruses In Vitro

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
3score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Description
1 study reviewed
In plain English

A nasal spray called Thymogen can kill a common cold-like virus in lab tests, starting at a certain strength, which might help fight off this virus in people.

See the scientific wording

Thymogen nasal spray demonstrates virucidal activity against respiratory syncytial virus in vitro, with effects beginning at a concentration of 1.2% in Vero cell cultures, indicating potential antiviral properties against this common respiratory pathogen.

What the research says

1 study

  1. Study: Virucidal Activity of the Drug «Thymogen®», a Nasal Dosed Spray, Against Human Respiratory Viruses In Vitro

    The study tested the same nasal spray as mentioned in the claim and found it kills the RSV virus in lab tests starting at a 1.2% concentration, just like the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.